DEBORAH JOHNSON: Open Payments
NPI 1558750950 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 100 payments from 20 companies in 2025. Trend: 2023 $2,414 · 2024 $1,732 · 2025 $1,529
Food & beverage: $1,529
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $299 |
| ABBVIE INC. | 19 | $209 |
| AstraZeneca Pharmaceuticals LP | 9 | $173 |
| Lilly USA, LLC | 11 | $154 |
| PFIZER INC. | 9 | $142 |
| Axsome Therapeutics, Inc. | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 5 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Dexcom, Inc. | 2 | $51 |
| Globus Medical, Inc. | 2 | $47 |
Products named: MOUNJARO, VRAYLAR, NURTEC ODT, Wegovy, Ozempic, Rybelsus, BREZTRI, CAPLYTA.
Industry payments across NC — which companies pay providers there.
